Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,319
Out of 4,876 analysts
55
Total ratings
68.09%
Success rate
24.57%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $134.38 | -10.70% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $78.21 | +66.22% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $65.01 | +69.20% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.00 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $86.33 | -63.80% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $10.50 | +233.33% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $119.47 | +146.92% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $45.75 | +98.91% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $81.49 | -66.87% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $313.08 | -78.60% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $134.38
Upside: -10.70%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $78.21
Upside: +66.22%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $65.01
Upside: +69.20%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.00
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $86.33
Upside: -63.80%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $10.50
Upside: +233.33%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $119.47
Upside: +146.92%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $45.75
Upside: +98.91%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $81.49
Upside: -66.87%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $313.08
Upside: -78.60%